CompanyGraph
Seikagaku Corporation
4548 · Japan
Price data from its SKUNF listing on OTC, quoted in USD
seikagaku.co.jpFinancials as of FY2026
What stands out
- Earnings significantly exceed cash generation
- Pays more per share than it earned over the last twelve months
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $239.52M, lower than 95% of all stocks globally
- PositionPrice-to-book is 0.52×, lower than 95% of its Medical Devices peers (median 2.69×)
- Interpretations8 currently firing — 8
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
What stands out
- Pays more per share than it earned over the last twelve months
Dividends view
Yield
4.23%Above 5Y avg (3.29%)
Annual Rate
JPY 30.00Paid semi-annual
Payout Ratio
111.1%High
Payback Period
0.1 yr
Next Ex-Dividend
Sep 29, 2026
The reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
37.95BJPY239.52M · vs all stocks (USD)
Trailing P/E
26.07xvs Medical Devices peers
Revenue (TTM)
36.75BJPY231.93M · vs all stocks (USD)
Profit Margin
4.52%vs Medical Devices peers
Beta
0.2190xvs all stocks
52-Week Change
5.82%vs all stocks
Forward Annual Dividend Yield
4.23%vs all stocks
Market Capitalization
37.95BJPY239.52M · vs all stocks (USD)
Enterprise Value
24.84BJPY156.77M · vs all stocks (USD)
Trailing P/E
26.07xvs Medical Devices peers
Forward P/E
14.20xvs Medical Devices peers
Price to Sales (TTM)
1.04xvs Medical Devices peers
Price to Book (MRQ)
0.5174xvs Medical Devices peers
Enterprise to Revenue
0.6760xvs Medical Devices peers
Enterprise to EBITDA
25.42xvs Medical Devices peers
Profit Margin
4.52%vs Medical Devices peers
Operating Margin
-10.68%vs Medical Devices peers
Return on Assets (TTM)
-0.94%vs Medical Devices peers
Return on Equity (TTM)
2.28%vs Medical Devices peers
Revenue (TTM)
36.75BJPY231.93M · vs all stocks (USD)
Revenue per Share (TTM)
673.01JPYUpdated Aug 20, 2026Quarterly Revenue Growth
1.20%vs Medical Devices peers
Gross Profit (TTM)
15.52BJPY97.96M · vs all stocks (USD)
EBITDA (TTM)
2.60BJPY16.42M · vs all stocks (USD)
Net Income (TTM)
1.66BJPY10.49M · vs all stocks (USD)
Operating Cash Flow (TTM)
-1.35BJPY-8.50M · vs all stocks (USD)
Forward Annual Dividend Rate
30.00JPYUpdated Aug 20, 2026Forward Annual Dividend Yield
4.23%vs all stocks
Trailing Annual Dividend Rate
30.00JPYUpdated Aug 20, 2026Trailing Annual Dividend Yield
4.23%vs all stocks
5-Year Average Dividend Yield
3.29%vs all stocks
Payout Ratio
111.15%vs Medical Devices peers
Revenue
36.65BJPYFY2026 · Mar 31, 2026Cost of Goods Sold
20.67BJPYFY2026 · Mar 31, 2026Gross Profit
15.97BJPYFY2026 · Mar 31, 2026Operating Income
-658.00MJPY-4.15M · vs all stocks (USD)
Pre-tax Income
1.51BJPYFY2026 · Mar 31, 2026Income Tax Expense
36.00MJPYFY2026 · Mar 31, 2026Net Income
1.47BJPYFY2026 · Mar 31, 2026EBIT
1.52BJPYFY2026 · Mar 31, 2026EBITDA (Income Statement)
2.60BJPYFY2026 · Mar 31, 2026Research & Development
7.01BJPYFY2026 · Mar 31, 2026Other Operating Expenses
5.85BJPYFY2026 · Mar 31, 2026Non-operating Interest Income
110.00MJPYFY2026 · Mar 31, 2026Non-operating Interest Expense
9.00MJPYFY2026 · Mar 31, 2026EPS (Basic)
26.99JPYFY2026 · Mar 31, 2026EPS (Diluted)
26.99JPYFY2026 · Mar 31, 2026Basic Shares Outstanding
54.59MSharesFY2026 · Mar 31, 2026Diluted Shares Outstanding
54.59MSharesFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00JPYFY2026 · Mar 31, 2026Operating Cash Flow
-2.12BJPYFY2026 · Mar 31, 2026Free Cash Flow
-8.02BJPYFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
12.06BJPYFY2026 · Mar 31, 2026Starting Profit (CF Statement)
1.51BJPYFY2026 · Mar 31, 2026Other Non-cash Items
-990.00MJPYFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-1.26BJPYFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-1.37BJPYFY2026 · Mar 31, 2026Capital Expenditures
-5.90BJPYFY2026 · Mar 31, 2026Net Intangibles (CF)
-124.00MJPYFY2026 · Mar 31, 2026Purchase of Investments
-1.66BJPYFY2026 · Mar 31, 2026Sale of Investments
4.17BJPYFY2026 · Mar 31, 2026Other Investing Activity
6.00MJPYFY2026 · Mar 31, 2026Net Investing Cash Flow
-3.38BJPYFY2026 · Mar 31, 2026Common Dividends Paid
-1.64BJPYFY2026 · Mar 31, 2026Other Financing Charges
-1.00MJPYFY2026 · Mar 31, 2026Net Financing Cash Flow
-1.64BJPYFY2026 · Mar 31, 2026Shares Outstanding
54.60MSharesUpdated Aug 20, 2026Float Shares
30.66MSharesUpdated Aug 20, 2026% Held by Insiders
42.27%vs all stocks
% Held by Institutions
16.65%vs all stocks
Total Cash (MRQ)
14.17BJPY89.45M · vs all stocks (USD)
Total Cash per Share (MRQ)
259.57JPYUpdated Aug 20, 2026Total Debt (MRQ)
353.00MJPY2.23M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0048xvs Medical Devices peers
Current Ratio (MRQ)
5.64xvs Medical Devices peers
Book Value per Share (MRQ)
1.36KJPYUpdated Aug 20, 2026Total Assets
86.34BJPY544.96M · vs all stocks (USD)
Total Current Assets
40.57BJPYFY2026 · Mar 31, 2026Total Liabilities
11.05BJPYFY2026 · Mar 31, 2026Total Non-current Assets
45.77BJPYFY2026 · Mar 31, 2026Total Non-current Liabilities
3.45BJPYFY2026 · Mar 31, 2026Total Current Liabilities
7.59BJPYFY2026 · Mar 31, 2026Cash & Cash Equivalents
8.94BJPYFY2026 · Mar 31, 2026Other Short-term Investments
6.01BJPYFY2026 · Mar 31, 2026Accounts Receivable
8.50BJPYFY2026 · Mar 31, 2026Inventory
11.25BJPYFY2026 · Mar 31, 2026Accounts Payable
1.04BJPYFY2026 · Mar 31, 2026Short-term Debt
327.00MJPYFY2026 · Mar 31, 2026Other Current Liabilities
1.77BJPYFY2026 · Mar 31, 2026Long-term Debt
29.00MJPYFY2026 · Mar 31, 2026Other Non-current Liabilities
109.00MJPYFY2026 · Mar 31, 2026Common Stock (Book)
3.84BJPYFY2026 · Mar 31, 2026Retained Earnings
54.25BJPYFY2026 · Mar 31, 2026Total Shareholders' Equity
75.30BJPY475.25M · vs all stocks (USD)
Treasury Stock
2.22BJPYFY2026 · Mar 31, 202652-Week Low
644.00JPYUpdated Aug 20, 202652-Week High
820.00JPYUpdated Aug 20, 202652-Week Change
5.82%vs all stocks
Beta
0.2190xvs all stocks
50-Day MA
723.44JPYUpdated Aug 20, 2026200-Day MA
718.46JPYUpdated Aug 20, 2026Avg 10-Day Volume
173.03KSharesUpdated Aug 20, 2026Avg 30-Day Volume
128.22KSharesUpdated Aug 20, 2026Diluted EPS (TTM)
26.97JPYUpdated Aug 20, 20268 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Retained Earnings Heavy With Elevated Payout
Profits kept in the business fund much of what it owns, and it now pays out most of what it earns.
Reads
How does this company use capital?
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
Low RSI With Profitability And Equity Ratio
Recent weekly losses have outpaced gains, on three profitable years and heavy equity.
Reads
Near All-Time Low With Profitability
Within 5% of its all-time low, profitable three years, and equity-funded.
Reads
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
Price Below Mean With Profitability And Equity
Price sits well below its yearly mean, profitable three years, and its equity ratio is high for its industry.
Reads
Where is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Price-to-book is 0.52×, lower than 95% of its Medical Devices peers (median 2.69×)Notable
Price-to-book: 0.52Industry median: 2.69Industry P5: 0.66Peers compared: 102
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 10,489,879.2Operating Cash Flow (USD, TTM): -8,501,725.2
Pays more per share than it earned over the last twelve monthsSignificant
Payout Ratio: 1.11Dividend per Share: 30.00Earnings per Share: 26.97
Financial Health
Altman Z-Score 3.88: safe zoneNotable
Altman Z-Score: 3.88
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $239.52M, lower than 95% of all stocks globallySignificant
Market cap (USD): 239,519,418.567Global P5: 269,387,740.27
Companies that share the same coordination system — how they create, deliver, or capture value.
Greenwich LifeSciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Shenqi Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Immunotech Biopharm Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Fulcrum Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Heartseed Inc.
Tier 1ProductionApproval-Gated PipelineRule
Sisram Medical Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hangzhou Jiuyuan Gene Engineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Siga Technologies Inc.
Tier 1ProductionApproval-Gated PipelineRule
Daito Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Protara Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Sino Wealth Electronic Ltd.
5 interpretationsHigh Retained Earnings With Profitability And EquityMinimal Tax and Interest DragRetained Earnings Heavy With Elevated PayoutPrice Below Mean With Profitability And Book ValuePrice Below Mean With Profitability And Equity
Motomotion China Corp.
4 interpretationsHigh Retained Earnings With Profitability And EquityLow RSI With Profitability And Equity RatioPrice Below Mean With Profitability And Book ValuePrice Below Mean With Profitability And Equity
Patanjali Foods Ltd.
4 interpretationsMinimal Tax and Interest DragLow RSI With Profitability And Equity RatioPrice Below Mean With Profitability And Book ValuePrice Below Mean With Profitability And Equity